Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Belite Bio to Participate in the Leerink Global Healthcare Conference
Belite Bio, a clinical-stage drug development company, announced its participation in a fireside chat at the Leerink Global Healthcare Conference on March 9, 2026, at 1:00 PM ET. The company focuses on developing novel therapeutics for degenerative retinal diseases and plans to make the webcast available on its investor relations website. Belite Bio’s lead candidate, tinlarebant, is currently undergoing Phase 2/3 and Phase 3 trials for Stargardt disease type 1 and geographic atrophy.